Elanco Animal Health Comprehensive Income 2016-2024 | ELAN

Elanco Animal Health comprehensive income from 2016 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Elanco Animal Health comprehensive income for the quarter ending September 30, 2024 was $-0.339B, a 29.67% decline year-over-year.
  • Elanco Animal Health comprehensive income for 2023 was $-0.266B, a 32.14% decline from 2022.
  • Elanco Animal Health comprehensive income for 2022 was $-0.392B, a 87.56% increase from 2021.
  • Elanco Animal Health comprehensive income for 2021 was $-0.209B, a 168.98% decline from 2020.
Elanco Animal Health Annual Comprehensive Income
(Millions of US $)
2023 $-266
2022 $-392
2021 $-209
2020 $303
2019 $-174
2018 $-222
2017 $-257
2016 $-457
2015 $
Elanco Animal Health Quarterly Comprehensive Income
(Millions of US $)
2024-09-30 $-339
2024-06-30 $-542
2024-03-31 $-465
2023-12-31 $-266
2023-09-30 $-482
2023-06-30 $-281
2023-03-31 $-310
2022-12-31 $-392
2022-09-30 $-1,007
2022-06-30 $-649
2022-03-31 $-186
2021-12-31 $-209
2021-09-30 $-146
2021-06-30 $65
2021-03-31 $-102
2020-12-31 $303
2020-09-30 $-122
2020-06-30 $-215
2020-03-31 $-243
2019-12-31 $-174
2019-09-30 $-253
2019-06-30 $-215
2019-03-31 $-250
2018-12-31 $-222
2018-09-30 $-210
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $6.605B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 0.00
Quest Diagnostics (DGX) United States $18.259B 18.51
DaVita (DVA) United States $13.572B 17.55
Encompass Health (EHC) United States $10.188B 24.02
Chemed (CHE) United States $8.593B 26.41
RadNet (RDNT) United States $6.073B 134.49
Option Care Health (OPCH) United States $3.936B 18.65
Amedisys (AMED) United States $2.969B 21.13
LifeStance Health (LFST) United States $2.832B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.254B 26.45
U.S Physical Therapy (USPH) United States $1.477B 38.82
Aveanna Healthcare Holdings (AVAH) United States $1.128B 0.00
Pennant (PNTG) United States $1.070B 43.25
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00